“Breaking News: AbbVie Partners with Neomorph to Develop Revolutionary Molecular Glue Degraders”
AbbVie Partners with Neomorph to Develop Novel Drugs About the Partnership AbbVie, a leading pharmaceutical company, has recently announced a partnership with Neomorph, a biotechnology company known for its innovative drug development platform. Per the terms of the deal, AbbVie will utilize Neomorph’s proprietary platform to develop novel drugs targeting oncology and immunology indications. This…